LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 945 | 4012 | 0.2362 | -0.1332 |
MCF7 | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1299 | 4203 | 0.3095 | 0.0403 |
MCF7 | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1616 | 4203 | 0.3852 | 0.1753 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3840 | 4012 | 0.9565 | 0.9487 |
MCF7 | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 707 | 4012 | 0.1766 | -0.2676 |
MCF7 | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3926 | 4012 | 0.9796 | 0.9771 |
MCF7 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3307 | 4012 | 0.8205 | 0.7759 |
MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1326 | 4012 | 0.3306 | 0.0542 |
MCF7 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1545 | 4012 | 0.3848 | 0.1507 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1426 | 4203 | 0.3400 | 0.0963 |
MCF7 | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 642 | 4203 | 0.1534 | -0.2971 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1316 | 4203 | 0.3136 | 0.0480 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3332 | 4203 | 0.7963 | 0.7620 |
MCF7 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 694 | 4012 | 0.1731 | -0.2752 |
MCF7 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3762 | 4203 | 0.8966 | 0.8829 |
MCF7 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 993 | 4012 | 0.2477 | -0.1080 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1982 | 4012 | 0.4938 | 0.3291 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1390 | 4203 | 0.3315 | 0.0809 |
MCF7 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3016 | 4203 | 0.7184 | 0.6637 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1310 | 4012 | 0.3271 | 0.0475 |
MCF7 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 502 | 4012 | 0.1251 | -0.3993 |
MCF7 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 985 | 4012 | 0.2457 | -0.1122 |
MCF7 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3843 | 4012 | 0.9590 | 0.9528 |
MCF7 | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3126 | 4012 | 0.7808 | 0.7336 |
MCF7 | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1427 | 4012 | 0.3561 | 0.1001 |